Conjunctival inflammatory cells and their predictive role for deep sclerectomy in primary open-angle glaucoma and exfoliation glaucoma

Journal of Glaucoma

Volumn 20, Issue 3, 2011, Pages 172-178

  Helin, Minna ^a   Rönkkö, Seppo ^a   Puustjärvi, Tuomo ^b   Teräsvirta, Markku ^a,b   Ollikainen, Minna ^b   Uusitalo, Hannu ^a,b,c  

^a UNIVERSITY OF EASTERN FINLAND   (Finland)

^b KUOPIO UNIVERSITY HOSPITAL   (Finland)

^c TAMPERE UNIVERSITY OF TECHNOLOGY   (Finland)

Author keywords

conjunctiva; deep sclerectomy; inflammation

Indexed keywords

ADRENALIN; APRACLONIDINE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BRIMONIDINE; CARBONATE DEHYDRATASE INHIBITOR; CD20 ANTIGEN; CD3 ANTIGEN; CD38 ANTIGEN; CD4 ANTIGEN; CD45RA ANTIGEN; CD68 ANTIGEN; CD8 ANTIGEN; MIOTIC AGENT; PROSTAGLANDIN DERIVATIVE;

ADULT; AGED; ARTICLE; B LYMPHOCYTE; CELL COUNT; CLINICAL ARTICLE; CONJUNCTIVA; CONTROLLED STUDY; CORRELATION ANALYSIS; CYTOTOXIC LYMPHOCYTE; EXFOLIATION SYNDROME; HELPER CELL; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INFLAMMATION; INFLAMMATORY CELL; MACROPHAGE; MEDICAL HISTORY; OPEN ANGLE GLAUCOMA; PLASMA CELL; PRIORITY JOURNAL; PROSPECTIVE STUDY; SCLERECTOMY; T LYMPHOCYTE; TREATMENT FAILURE;

AGED; ANTIGENS, CD; ANTIHYPERTENSIVE AGENTS; B-LYMPHOCYTES; CELL COUNT; CONJUNCTIVITIS; EXFOLIATION SYNDROME; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; GLAUCOMA, OPEN-ANGLE; HUMANS; MACROPHAGES; MIDDLE AGED; PROSPECTIVE STUDIES; SCLEROSTOMY; T-LYMPHOCYTES;

EID: 79952694876     PISSN: 10570829     EISSN: None     Source Type: Journal    
DOI: 10.1097/IJG.0b013e3181d9ccb0     Document Type: Article

References (40)

1. Weinreb RN, Khaw PT. Primary open-angle glaucoma. Lancet. 2004;363:1711-1720. (Pubitemid 38670330)
2. Lee DA, Higginbotham EJ. Glaucoma and its treatment: a review. Am J Health Syst Pharm. 2005;62:691-699. (Pubitemid 40462838)
3. Coleman AL. Glaucoma. Lancet. 1999;354:1803-1810.
4. Foster PJ, Buhrman R, Quigley HA, et al. The definition and classification of glaucoma in prevalence surveys. Br J Ophthalmol. 2001;86:238-242.
5. Forsius H. Prevalence of pseudoexfoliation of the lens in Finns, Lapps, Icelanders, Eskimos and Russians. Trans Ophthalmol Soc UK. 1979;99:296-298. (Pubitemid 10074872)
6. Krause U, Helve J, Forsius H. Pseudoexfoliation of the lens capsule and liberation of iris pigment. Acta Ophthalmol (Copenh). 1973;51:39-46.
7. Krause U, Alanko HI, Kärnä J, et al. Prevalence of exfoliation syndrome in Finland. Acta Ophthalmol Suppl. 1988;184:120-122.
8. Aasved H. The frequency of optic nerve damage and surgical treatment in chronic simple glaucoma and capsular glaucoma. Acta Ophthalmol. 1971;49:589-600.
9. Futa R, Shimizu T, Furuyoshi N, et al. Clinical features of capsular glaucoma in comparison with primary open-angle glaucoma in Japan. Acta Ophthalmol. 1992;70:214-219.
10. Konstas AG, Stewart WC, Stroman GA, et al. Clinical presentation and initial treatment patterns in patients with exfoliation glaucoma versus primary open-angle glaucoma. Ophthalmic Surg Lasers. 1997;28:111-117.
11. Lindblom B, Thorburn W. Prevalence of visual field defects due to capsular and simple glaucoma in Halsingland, Sweden. Acta Ophthalmol. 1982;60:353-361.
12. Lindblom B, Thorburn W. Functional damage at diagnosis of primary open-angle glaucoma. Acta Ophthalmol. 1984;62:223-229. (Pubitemid 14161436)
13. Tarkkanen A. Pseudoexfoliation of the lens capsule. A clinical study of 418 patients with special reference to glaucoma, cataract, and changes of the vitreous. Acta Ophthalmol Suppl. 1962;71:1-98.
14. Jaenen N, Baudouin C, Pouliquen P, et al. Ocular symptoms and signs with preserved and preservative-free glaucoma medications. Eur J Ophthalmol. 2007;17:341-349. (Pubitemid 47056287)
15. Leung EW, Medeiros FA, Weinreb RN. Prevalence of ocular surface disease in glaucoma patients. J Glaucoma. 2008;17:350-355.
16. Baudouin C, Pisella PJ, Fillacier K, et al. Ocular surface inflammatory changes induced by topical antiglaucoma drugs: human and animal studies. Ophthalmology. 1999;106:556-563. (Pubitemid 30191592)
17. Becquet F, Goldschild M, Moldovan MS, et al. Histopathological effects of topical ophthalmic preservatives on rat corneoconjunctival surface. Curr Eye Res. 1998;17:419-425. (Pubitemid 28178417)
18. Broadway DC, Grierson I, O'Brien C, et al. Adverse effects of topical antiglaucoma medication. I. The conjunctival cell profile. Arch Ophthalmol. 1994a;112:1437-1445.
19. Broadway DC, Grierson I, O'Brien C, et al. Adverse effects of topical antiglaucoma medication. II. The outcome of filtration surgery. Arch Ophthalmol. 1994b;112:1446-1454.
20. Nenciu A, Stefan C, Ardelean C. Structural and immunohistochemical changes of conjunctiva induced by topical glaucoma medication. Oftalmologia. 2004;48:35-42.
21. Nuzzi R, Finazzo C, Vercelli A, et al. Conjunctiva and subconjunctival tissue in primary open-angle glaucoma after long-term topical treatment: an immunohistochemical and ultrastructural study. Graefes Arch Clin Exp Ophthalmol. 1995;233:154-162.
22. Baudouin C, Garcher C, Haouat N, et al. Expression of inflammatory membrane markers by conjunctival cells in chronically treated patients with glaucoma. Opththalmology. 1994;101:454-460. (Pubitemid 24100569)
23. Sherwood MB, Grierson I, Millar L, et al. Long-term morphologic effects of antiglaucoma drugs on the conjunctiva and Tenońs capsule in glaucomatous patients. Ophthalmology. 1989;96:327-335. (Pubitemid 19078905)
24. Broadway DC, Grierson I, Sturmer J, et al. Reversal of topical antiglaucoma medication effects on the conjunctiva. Arch Ophthalmol. 1996;114:262-267. (Pubitemid 26086730)
25. Demailly P, Lavat P, Kretz G, et al. Non-penetrating deep sclerectomy (NPDS) with or without collagen device (CD) in primary open-angle glaucoma: middle-term retrospective study. International Ophthalmol. 1996;20:131-140. (Pubitemid 27130491)
26. Drolsum L. Longterm follow-up after deep sclerectomy in patients with pseudoexfoliative glaucoma. Acta Ophthalmol Scand. 2006;84:502-506. (Pubitemid 44102847)
27. El-Sayyad F, Helal M, El-Kholify H, et al. Nonpenetrating deep sclerectomy versus trabeculectomy in bilateral primary open-angle glaucoma. Ophthalmology. 2000;107:1671-1674.
28. Rekonen P, Kannisto T, Puustjärvi T, et al. Deep sclerectomy for the treatment of exfoliation and primary open-angle glaucoma. Acta Ophthalmol Scand. 2006;84:507-511. (Pubitemid 44109047)
29. Sanchez E, Schnyder CC, Mermoud A. Comparative results of deep sclerectomy transformed to trabeculectomy and classical trabeculectomy. Klin Monatsbl Augenheilkd. 1997;210:261-264. (Pubitemid 27405036)
30. Wishart PK, Wishart MS, Porooshani H. Viscocanalostomy and deep sclerectomy for the surgical treatment of glaucoma: a long term follow-up. Acta Ophthalmologica Scandinavica. 2003;81:343-348. (Pubitemid 36926861)
31. Rönkkö S, Rekonen P, Kaarniranta K, et al. Matrix metalloproteinases and their inhibitors in chamber angle of normal eyes and patients with primary open-angle glaucoma and exfoliation glaucoma. Graefes Arch Clin Exp Ophthalmol. 2007;245:697-704.
32. Kumar V, Abbas AK, Fausto N, ed. Robbins and Contran Pathologic Basis of Disease. Philadelphia: Elsevier Saunders; 2005.
33. Noecker RJ, Herrygers LA, Anwaruddin R. Corneal and conjunctival changes caused by commonly used glaucoma medications. Cornea. 2004;23:490-496. (Pubitemid 38857008)
34. Arici MK, Demircan S, Topalkara A, et al. Effect of conjunctival structure and inflammatory cell counts on intraocular pressure after trabeculectomy. Ophthalmologica. 1999;213:371-375. (Pubitemid 29524924)
35. Arici MK, Arici DS, Topalkara A, et al. Adverse effects of topical antiglaucoma drugs on the ocular surface. Clin Experiment Ophthalmol. 2000;28:113-117. (Pubitemid 30458440)
36. Brandt JD, Wittpenn JR, Katz LJ, et al. Conjunctival impression cytology in patients with glaucoma using longterm topical medication. Am J Ophthalmol. 1991;112:297-301.
37. Herreras JM, Pastor JC, Calonge M, et al. Ocular surface alteration after long-term treatment with an antiglaucomatous drug. Ophthalmology. 1992;99:1082-1088.
38. Hong S, Lee CS, Seo KY, et al. Effects of topical antiglaucoma application on conjunctival impression cytology specimens. Am J Ophthalmol. 2006;142:185-186. (Pubitemid 43946804)
39. Yalvac IS, Gedikoglu G, Karagoz Y, et al. Effects of antiglaucoma drugs on ocular surface. Acta Ophthalmol Scand. 1995;73:246-248.
40. Konstas AG, Tsatsos I, Kardasopoulos A, et al. Preoperative features of patients with exfoliation glaucoma and primary open-angle glaucoma. The AHEPA study. Acta Ophthalmol Scand. 1998;76:208-212.